摘要：以往护士在进行加压静脉输液时,常采用一次性注射器抽吸空气后,向输液瓶内注入,同时夹紧输液器通气管道使瓶内压力增高而达到快速输液的目的.其缺点是操作复杂,反复注入空气容易造成液体外流和微粒污染.为提高工作效率,防止液体外流和微粒污染,避免输液反应的发生,我们于1999年6月设计了静脉输液加压装置,经临床使用效果满意,现介绍如下。

摘要：目的探讨门诊输液室持续质量改进措施,提高输液室护理质量。方法运用PDCA方法,设计并实施提高输液室护理工作流程和质量考核标准。结果门诊输液室护理工作各项考核指标显著提高,2003～2006年输液50423例病员,病员满意度为98%,院内感染率为0,输液反应发生率为0,门诊输液投诉事件发生率为0,差错发生率为0。结论采用PDCA管理模式制定输液室质量考核标准,认真执行输液室管理流程,输液室中护理质量显著提高。

摘要：Objective: To evaluate the use of tumor necrosis factor (TNF)-αblockade for treatment of patients with Kawasaki syndrome (KS) who fail to become afebrile or who experience persistent arthritis after treatment with intravenous gamma glob ulin (IVIG) and high-dose aspirin. Study design: Cases were retrospectively col lected from clinicians throughout the United States who had used infliximab, a c himeric murine/human immunoglobulin (Ig)G1monoclonal antibody that binds specifi cally to human TNF-α-1, for patients with KS who had either persistent arthri tis or persistent or recrudescent fever ≥48 hours following infusion of 2 g/kg of IVIG. Results: Response to therapy with cessation of fever occurred in 13 of 16 patients. C-reactive protein (CRP) levelwas elevated in all but one patient before infliximab infusion, and the level was lower following infusion in all 10 patients in whom it was remeasured within 48 hours of treatment. There were no infusion reactions to infliximab and no complications attributed to infliximab a dministration in any of the patients. Conclusion: The success of TNF-αblockade in this small series of patients suggests a central role of TNF-αin KS pathog enesis. Controlled, randomized clinical trials are warranted to determine the ro le of anti-TNF-αtherapy in KS.